Treatment of Metastatic Extramammary Paget Disease with Combination Ipilimumab and Nivolumab: A Case Report

Metastatic primary cutaneous extramammary Paget disease (EMPD) is a rare clinical entity with a 5-year survival <10% and no standard therapy. We report the first case to our knowledge of metastatic EMPD with treatment response to checkpoint inhibitor immunotherapy. The patient had diffusely met...

全面介紹

書目詳細資料

Principais autores:	Brendan John Guercio, Gopa Iyer, Wajih Zaheer Kidwai, Mario E. Lacouture, Soleen Ghafoor, Anthony M. Rossi, David N. Assis, Ying-Bei Chen, Klaus J. Busam, Yelena Y. Janjigian, Komal Jhaveri, Darren R. Feldman, Anne Capozzi, Vanessa Figueroa, Dean F. Bajorin, Jonathan E. Rosenberg, Travis J. Hollmann, Samuel A. Funt
格式:	Artigo
語言:	Inglês
出版:	Karger Publishers 2021-03-01
叢編:	Case Reports in Oncology
主題:	extramammary paget disease immunotherapy nivolumab ipilimumab immune checkpoint blockade
在線閱讀:	http://prod.karger.com/Article/FullText/514345
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!